Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
Clinical trial NCT05047692 · COMPLETED
Trial details
- NCT number
- NCT05047692
- Sponsor
- Cellid Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2022-12-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.